Strategic Global Advisors, LLC

Position in ONC — BeOne Medicines Ltd.

CIK 1580212 NEWPORT BEACH, CA

Position in ONC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$793,071

+$378,204 QoQ

Shares Held

2,783

+99.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#136

of 282 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

Strategic Global Advisors, LLC holds $8,606,227 across 4 Biotechnology names. ONC ranks #4 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	97,747	$5,318,414
2	ALNY	Alnylam Pharmaceuticals, Inc.	4,823	$1,451,867
3	ASND	Ascendis Pharma A/S	3,910	$1,042,875
4	ONC	BeOne Medicines Ltd. This page	2,783	$793,071

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$793,071	2,783	+99.2%	Shares	Sole	2026-08-14
2026-03-31	$414,867	1,397	+26.3%	Shares	Sole	2026-05-15
2025-12-31	$336,013	1,106	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.